BNP Paribas to Return Around $22 Billion to Shareholders Through 2026 — Update
By Adria Calatayud
BNP Paribas said it aims to return about 20 billion euros ($21.86 billion) to shareholders between 2024 and 2026, becoming the latest European bank to splash out on payouts.
The French bank on Wednesday said it planned to accelerate and widen an existing cost-savings plan by EUR400 million, raising its target for the 2022-25 program to EUR2.7 billion.
With its plans to boost shareholder returns, BNP Paribas joins other European banks that have ramped up dividends and buybacks even as they brace for potential cuts to interest rates. Italy's UniCredit, the U.K.'s Barclays and Germany's Deutsche Bank are among the banks that outlined plans to return more cash to shareholders in recent weeks.
BNP Paribas said it expects 2024 net profit will be higher than 2023 distributable net profit. The bank last month said it targeted annual growth in net profit of around 8% for the 2022-25 period.
It also confirmed its profitability targets, which call for a return on tangible equity--a key measure of profitability for banks--of between 11.5% and 12% in 2025 and of 12% a year later.
This profit trajectory should enable the group to boost shareholder returns to EUR20 billion, BNP Paribas said. When it reported fourth-quarter results in February, BNP Paribas said it would launch a share buyback of EUR1.05 billion in 2024 and raised its 2023 dividend by 18% to EUR4.60 a share.
The bank said it expects to continue to grow faster than its underlying economy and to gain market share.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
March 13, 2024 03:43 ET (07:43 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth